SHARON LaFRANIERE

Outside experts will make their recommendations this week on how the agency should rule on applications from Pfizer and Moderna to vaccinate the nation’s youngest...

Outside experts will meet next week to decide whether to recommend that the agency authorize the vaccine for kids 6 months and older.

The findings indicate that the updated vaccine produced a significantly stronger immune response against Omicron, but it is unclear how it will fare against future...

Previously, the agency said those 50 and older could opt for the additional shot, but encouraged only people over 65 or with underlying medical conditions...

More than eight million of the 28 million children in that age group in the United States have received two vaccine shots.

Given that the age group has the lowest coronavirus vaccination rate of all eligible Americans, public health experts are not expecting a rush for the...

The agency said the move reflected an updated analysis of the risk of a rare but serious blood-clotting condition in people who get the vaccine.

Both Moderna and Pfizer-BioNTech have asked the agency to approve their vaccines for the youngest children.

Pfizer and BioNTech will soon ask the Food and Drug Administration for emergency authorization of Covid booster doses for that age group, the companies said.